Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» multiple sclerois
multiple sclerois
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
New insight into how Biogen's Tecfidera works may lead to better MS therapies
Fierce Biotech
Sat, 03/2/19 - 12:49 pm
Biogen
Tecfidera
MS
multiple sclerois
R&D
Novartis pads case for new MS blockbuster with disease-progression analysis
Fierce Pharma
Sat, 04/21/18 - 12:41 pm
Novartis
MS
multiple sclerois
siponimod
Major restructuring with staff cuts in US for Teva
GoinPharma
Sun, 04/8/18 - 12:19 pm
Teva Pharmaceutical
M&A
restructuring
AssistRx
Parkinson's Disease
multiple sclerois
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Motley Fool
Wed, 02/14/18 - 11:20 am
Celgene
etrasimod
ozanimod
Arena Pharmaceuticals
MS
multiple sclerois